BioNTech Announces New ADS Repurchase Program

Summary by AI BETAClose X

BioNTech SE has announced a new share repurchase program authorizing up to $1.0 billion in American Depositary Shares (ADSs) to be repurchased until May 6, 2027, funded by existing cash resources. This initiative aims to enhance capital efficiency, support long-term value creation, and maintain financial flexibility as the company pursues its goal of becoming a multi-product company by 2030. Repurchases will be conducted in the open market, focusing on price efficiency, and are expected to satisfy obligations in the ordinary course of business.

Disclaimer*

UK 100

Latest directors dealings